Company Profile
Vapotherm Stock Price, News & Analysis
- Ticker:
- VAPO
- Exchange:
- PINK
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for VAPO.
Company overview
Business overview
Vapotherm is a respiratory care medical technology company focused on high-velocity therapy systems used in hospitals and acute-care settings. Its business is driven by device adoption and clinical workflow rather than drug development.
Geographic Base and Sector Classification
Vapotherm is headquartered in the United States and listed on NASDAQ, with a medtech profile centered on respiratory support. It sits outside biotechnology proper.
Business Model Characteristics
The company generates value through device sales, recurring product usage, and hospital adoption. Investors usually focus on utilization, reimbursement, and whether the company can improve commercial execution and margins.
Position Within the Biotechnology Landscape
Vapotherm is best classified as hospital respiratory medtech rather than biotech. Its stock responds to device demand and operating execution, not to trial or FDA drug events.
Future catalysts
Vapotherm’s catalysts are respiratory-device adoption, hospital workflow growth, and margin execution. The company improves when the device becomes more standard in care pathways.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Vapotherm do?
Vapotherm is a respiratory care medical technology company focused on high-velocity therapy systems used in hospitals and acute-care settings. Its business is driven by device adoption and clinical workflow rather than drug development.
On which exchange is VAPO stock listed?
Vapotherm (VAPO) is associated with PINK, United States, Biopharma.
What is Vapotherm?
Vapotherm’s catalysts are respiratory-device adoption, hospital workflow growth, and margin execution.
Which conditions is Vapotherm targeting with Vapotherm?
Vapotherm is associated with respiratory disease based on its company overview and current catalyst commentary.
How does Vapotherm describe recent progress with Vapotherm?
Vapotherm’s catalysts are respiratory-device adoption, hospital workflow growth, and margin execution.
What future catalysts are investors watching for Vapotherm?
Vapotherm’s catalysts are respiratory-device adoption, hospital workflow growth, and margin execution. The company improves when the device becomes more standard in care pathways.